Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein.

Chiba S, Hill-Batorski L, Neumann G, Kawaoka Y.

Front Microbiol. 2018 Sep 12;9:2192. doi: 10.3389/fmicb.2018.02192. eCollection 2018.


The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection.

Halfmann P, Hill-Batorski L, Kawaoka Y.

J Infect Dis. 2018 Nov 22;218(suppl_5):S504-S507. doi: 10.1093/infdis/jiy433.


Ebola Virus Stability Under Hospital and Environmental Conditions.

Westhoff Smith D, Hill-Batorski L, N'jai A, Eisfeld AJ, Neumann G, Halfmann P, Kawaoka Y.

J Infect Dis. 2016 Oct 15;214(suppl 3):S142-S144. Epub 2016 Jun 7.


Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.

Hill-Batorski L, Halfmann P, Marzi A, Lopes TJ, Neumann G, Feldmann H, Kawaoka Y.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S329-35. doi: 10.1093/infdis/jiv335. Epub 2015 Jul 23.


Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus.

Taft AS, Ozawa M, Fitch A, Depasse JV, Halfmann PJ, Hill-Batorski L, Hatta M, Friedrich TC, Lopes TJ, Maher EA, Ghedin E, Macken CA, Neumann G, Kawaoka Y.

Nat Commun. 2015 Jun 17;6:7491. doi: 10.1038/ncomms8491.


Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates.

Marzi A, Halfmann P, Hill-Batorski L, Feldmann F, Shupert WL, Neumann G, Feldmann H, Kawaoka Y.

Science. 2015 Apr 24;348(6233):439-42. doi: 10.1126/science.aaa4919. Epub 2015 Mar 26.


The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication.

Hill-Batorski L, Halfmann P, Neumann G, Kawaoka Y.

J Virol. 2013 Dec;87(24):13795-802. doi: 10.1128/JVI.02422-13. Epub 2013 Oct 9.

Supplemental Content

Loading ...
Support Center